We focus on creating the highest possible value for our clients. To accomplish this goal, we: (1) assist late stage (listed) companies to optimize pipelines, processes and external collaborations to achieve market capitalization goals and (2) assist early and middle stage companies’ management to build prospective IPO/M&A opportunities from 1-3 years in advance by working out the company fundamentals and by properly sensitizing and preparing the target financial and industrial markets. 

We serve customers with solutions tailored to their specific needs, no matter the stage of development of their business, to help them grow in the complicate biotech business system. We work with life science and healthcare companies through all stages in the company’s life cycle, from early to developed firms: